Tuomas Kiviniemi
 MD, PhD, FESC

Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Pacemaker; Anticoagulation; Bleeding;

As a clinical cardiologist with a specific research interest in atrial fibrillation (AF) and long-term complications after percutaneous and surgical procedures, I have established a research group, which includes 10 PhD students at present. From a clinical point of view, my specific focus is AF patients undergoing cardiac procedures.



PI leads CAREFIB Consortium, which aims to reduce the burden of atrial fibrillation and its adverse outcome stroke in patients undergoing cardiac procedures. This consortium is divided into three major studies: a retrospective epidemiological CAREAVR study; a prospective CAREBANK biobank and a prospective LAA-CLOSURE trial.



Cardiology, ECG, Echocardiography, Atrial fibrillation, Anticoagulation




  
Go to first page
  
Go to previous page
  
1 of 10
  
Go to next page
  
Go to last page
  

Last updated on 2023-12-07 at 12:38